John Ransom
Stock Analyst at Raymond James
(3.72)
# 454
Out of 4,831 analysts
226
Total ratings
64.97%
Success rate
15.37%
Average return
Main Sectors:
Stocks Rated by John Ransom
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $311.38 | +73.42% | 13 | Apr 21, 2025 | |
RDNT RadNet | Upgrades: Strong Buy | $85 → $65 | $60.53 | +7.38% | 11 | Mar 5, 2025 | |
CI The Cigna Group | Reiterates: Strong Buy | $415 → $360 | $301.89 | +19.25% | 17 | Jan 31, 2025 | |
HCA HCA Healthcare | Downgrades: Market Perform | n/a | $368.10 | - | 21 | Nov 22, 2024 | |
THC Tenet Healthcare | Downgrades: Outperform | $195 | $157.70 | +23.65% | 17 | Nov 22, 2024 | |
CYH Community Health Systems | Downgrades: Underperform | n/a | $3.80 | - | 8 | Nov 22, 2024 | |
SCI Service Corporation International | Maintains: Outperform | $80 → $85 | $75.82 | +12.11% | 12 | Nov 1, 2024 | |
GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $4.30 | +132.56% | 2 | May 16, 2024 | |
EHC Encompass Health | Reiterates: Strong Buy | $85 → $95 | $117.61 | -19.22% | 15 | Apr 26, 2024 | |
WBA Walgreens Boots Alliance | Maintains: Market Perform | n/a | $11.37 | - | 7 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | n/a | $94.52 | - | 14 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $228.89 | - | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $16.92 | +18.20% | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $26.10 | +14.94% | 12 | Mar 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $14.05 | -14.59% | 9 | Jan 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $60.50 | +40.50% | 7 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $109.74 | -4.32% | 8 | Aug 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $3.52 | +184.09% | 4 | Aug 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.86 | - | 7 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.29 | - | 11 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $22.87 | - | 7 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $85 → $100 | $26.94 | +271.20% | 8 | Aug 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $45.59 | - | 2 | Feb 14, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $27.41 | - | 2 | Dec 20, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $143.98 | - | 8 | Nov 7, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $22.94 | - | 2 | Aug 9, 2017 |
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $311.38
Upside: +73.42%
RadNet
Mar 5, 2025
Upgrades: Strong Buy
Price Target: $85 → $65
Current: $60.53
Upside: +7.38%
The Cigna Group
Jan 31, 2025
Reiterates: Strong Buy
Price Target: $415 → $360
Current: $301.89
Upside: +19.25%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $368.10
Upside: -
Tenet Healthcare
Nov 22, 2024
Downgrades: Outperform
Price Target: $195
Current: $157.70
Upside: +23.65%
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $3.80
Upside: -
Service Corporation International
Nov 1, 2024
Maintains: Outperform
Price Target: $80 → $85
Current: $75.82
Upside: +12.11%
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $4.30
Upside: +132.56%
Encompass Health
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $117.61
Upside: -19.22%
Walgreens Boots Alliance
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $11.37
Upside: -
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $94.52
Upside: -
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $228.89
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $16.92
Upside: +18.20%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $26.10
Upside: +14.94%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $14.05
Upside: -14.59%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $60.50
Upside: +40.50%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $109.74
Upside: -4.32%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $3.52
Upside: +184.09%
May 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.86
Upside: -
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $4.29
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $22.87
Upside: -
Aug 1, 2022
Maintains: Strong Buy
Price Target: $85 → $100
Current: $26.94
Upside: +271.20%
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $45.59
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $27.41
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $143.98
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $22.94
Upside: -